CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE Healthcare announced today that it has completed a license agreement with Applied Biosystems, granting Applied Biosystems access to GE Healthcare patents for the biomagnetic isolation of nucleic acids. The license, which is valid for the lifetime of the patents, grants Applied Biosystems certain rights with respect to the isolation and purification of nucleic acids using GE Healthcare’s proprietary magnetic separation technology.
